Medicine sales value share in Russia 2020-2023, by origin

In 2023, pharmaceuticals of foreign origin comprised the largest share of Russian pharmaceutical commercial sales of medicines in monetary terms, at 51.9 percent. The share of revenue from domestic drug sales slightly increased from the previous year.

于2023年，源自外国的药品在俄罗斯药品商业销售中占据了最大的市场份额，以货币计算达到51.9%。相较于上一年，国内药品销售的收益份额略有上升。